The Future of theAndroid TV Box Market: Growth Trends, Market Size, and Opportunities to Watch
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theAngiotensin Receptor Blockers (ARBs) Market?
The angiotensin receptor blockers market is predicted to grow due to the rise in cardiovascular diseases. Cardiovascular diseases, conditions that impact the heart or blood vessels, often lead to fatty deposits within arteries (atherosclerosis) and a higher chance of blood clots. Angiotensin receptor blockers help lower blood pressure and enhance the heart’s ability to pump blood because they facilitate the relaxation of veins and arteries—this can reduce the risk of cardiovascular disease. For example, the American College of Cardiology, a professional medical institution based in the US, projected in August 2022 that the prevalence of cardiovascular risk factors and disease will substantially increase in the United States by 2060. As such, the escalating rates of cardiovascular diseases are stimulating the expansion of the angiotensin receptor blockers market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp
What is the Predicted Annual Growth Rate of theAngiotensin Receptor Blockers (ARBs) Market Impact Industry Trends by 2034?
In recent times, there has been a constant growth in the market size of angiotensin receptor blockers (ARBs). It’s projected to expand from a value of $8.51 billion in 2024 to around $8.87 billion in 2025, marking a compound annual growth rate (CAGR) of 4.1%. This substantial growth in the historical period is linked to various factors including the hypertension epidemic, clinical effectiveness, the burden of cardiovascular disease, renal protection, established clinical guidelines, the usage of ARBs as the initial treatment strategy, and their cost-effectiveness.
The market for angiotensin receptor blockers (ARBs) is predicted to experience consistent growth in the forthcoming years, reaching a value of $10.76 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this growth during the projection period include the adoption of precision medicine tactics, the promotion of combination therapies, the worldwide market expansion, the implementation of biomarker-related treatment strategies, government policies, and enhanced hypertension awareness. The forecast period will be marked by several key trends including the increased use of telemedicine, investment in research and development, competition from generic brands and patent terminations, the use of digital health tools to ensure medication compliance, and competition from biosimilars.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8943
How Are Consumer Market Innovations Shaping the Current and Future Landscape of theAngiotensin Receptor Blockers (ARBs) Market?
In the angiotensin receptor blocker market, top-tier companies are focusing on the creation of advanced products such as angiotensin receptor neprilysin inhibitors (ARNIs) to improve treatment choices and patient outcomes related to cardiovascular disorders. ARNIs are a type of drug often used to manage heart failure symptoms. For instance, in January 2023, Glenmark Pharmaceuticals, a pharmaceutical firm based in India, launched a product called sacubitril + valsartan tablets. These tablets are designed to treat heart failure, more specifically heart failure with reduced ejection fraction (HFrEF). This pairing falls under the ARNI category. Sacubitril improves the performance of the natriuretic peptide (NP) system, which reduces fluid overload and enables blood vessel dilation. Meanwhile, valsartan inhibits the renin-angiotensin system (RAS), resulting in lower blood pressure and a lighter workload for the heart. Together, these drugs not only improve symptoms of heart failure, but also diminish the risk of cardiovascular death and decrease the likelihood of being hospitalized due to heart failure. It is sold under the brand name Sacu V.
Who Are the Key Market Players Influencing the Growth of the Corn and Angiotensin Receptor Blockers (ARBs) Industry?
Major companies operating in the angiotensin receptor blockers (ARBs) market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Angiotensin Receptor Blockers (ARBs) Market and Drive Its Revenue Growth?
The angiotensin receptor blockers (ARBs) market covered in this report is segmented –
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Valsartan: Tablets, Capsules, Injectable Forms
2) By Telmisartan: Tablets, Capsules
3) By Losartan: Tablets, Oral Solution
4) By Irbesartan: Tablets, Oral Solution
5) By Azilsartan: Tablets
6) By Olmesartan: Tablets, Oral Suspension
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8943&type=smpGlobal Angiotensin Receptor Blockers (ARBs) Market, Global Angiotensin Receptor Blockers (ARBs) Market Report, Global Angiotensin Receptor Blockers (ARBs) Market Trends, Global Angiotensin Receptor Blockers (ARBs) Market Size
Browse Through More Reports Similar to the Gobal Angiotensin Receptor Blockers (ARBs) Maret 2025, By The Business Research Company:
Cold Plasma Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report
Porcine Plasma Feed Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/porcine-plasma-feed-global-market-report
Mycoplasma Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
